November - 2023
| Previous Next | Showing Journal 8 of 9 |
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection - The ACORN Randomized Clinical TrialE.T.Qian, J.D.Casey, A Wright, et al JAMA, 2023, 330(16):1557-1567 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
November |
Previous Comments
No Comments yet.
Comment
Cefepime and piperacillin-tazobactam are empirically used for hospitalised patients with gram negative bacteria. However studies report an association between pip-tax and acute kidney injury, particularly with concurrent use of vancomycin, and cefepime and neurotoxicity, as...